Cisplatin and 5-Fu Combined with Radiotherapy and Surgery in the Treatment of Squamous Cell Carcinoma of the Esophagus Palliative Effects and Tumor Response

References

• Marks R D, Scruggs H J, Wallace KM. Preoperative radiation therapy for carcinoma of the esophagus. Cancer 1976; 38: 84–9
   PubMed Web of Science ®Google Scholar
• Nakayama K, Kinoshita Y. Surgical treatment combined with preoperative concentrated irradiation. In: Current concepts in cancer No. 42. JAMA 1974; 227: 178–81
   PubMed Web of Science ®Google Scholar
• Launois B, Delarue D, Campion J P, Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981; 153: 690
   PubMedGoogle Scholar
• EORTC. Preoperative radiotherapy for carcinoma of the esophagus: results of a prospective multicentric study. Esophageal disorders: Pathosphysiology and therapy, T R DeMeester, D B Skinner. Raven Press, New York 1985; 367–71
   Google Scholar
• Hambraeus G M, Mercke C E, Willén R. Prognostic factors influencing survival in combined radiotherapy and surgery of squamous cell carcinoma of the oesophagus with special reference to a histopathological grading system. Cancer 1988; 62: 895–904
   PubMed Web of Science ®Google Scholar
• Schabel FM, Jr., Trader M W, Laster WR., Jr., Corbett T H, Griswold DP, Jr. Cis-dichlorodiammineplatinum (II): Combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep 1979; 63: 1459–73
   PubMedGoogle Scholar
• Kish J A, Weaver A, Jacobs J, Cummings G, Al-Sarraf M. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 1984; 53: 1819–24
   PubMed Web of Science ®Google Scholar
• Mercke C, Albertsson M, Björklund A, Hambraeus G, Samuelsson L, Sigurdsson H. High remission rate as a result of chemotherapy for a squamous cell carcinoma in the head and neck region and in the esophagus. Acta Societatis Sue-canae 1984; 227
   Google Scholar
• Rosenberg B, VanCamp L, Krigas T. Inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode. Nature 1965; 205: 698–9
   PubMed Web of Science ®Google Scholar
• Rosenberg J C, Schwade J G, Vaitkevicins VK. Cancer-principles and practice of oncology, V T DeVita, S Hellman, S A Rosenberg. Lippincott, Philadelphia 1982; 500
   Google Scholar
• Hankins J R, Cole F N, Attar S, et al. Carcinoma of the oesophagus: Experience with a philosophy for palliation. Ann Thorac Surg 1977; 23: 400–8
   PubMed Web of Science ®Google Scholar
• Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980; 67: 381–90
   PubMed Web of Science ®Google Scholar
• Earlam R, Cunha-Melo JR. Oesophageal sqamous cell carcinoma: II. A critical review of radiotherapy. Br J Surg 1980; 67: 457–61
   PubMed Web of Science ®Google Scholar
• Decker D A, Drelichman A, Jacobs J, et al. Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in stage II and IV squamous cell carcinoma of the head and neck. Cancer 1983; 51: 1353–5
   PubMed Web of Science ®Google Scholar
• Panettiere F J, Leichman L, O'Bryan R, Haas C, Fletcher W. Cis-diamminedichloride platinum (II), an effective agent in the treatment of epidermoid carcinoma of the oesophagus. Cancer Clin Trials 1981; 4: 29–31
   PubMedGoogle Scholar
• Dent R G, McColl I. 5-fluorouracil and angina. Lancet 1975; 1: 347–8
   PubMed Web of Science ®Google Scholar
• Labianca R, Beretta G, Clereci M, Fraschini P, Luporini G. Cardiac toxicity of 5-fluorouracil: A study on 1 083 patients. Tumori 1982; 68: 505–10
   PubMed Web of Science ®Google Scholar
• Underwood D A, Groppe C W, Tsai A R, Yiannikas J, Heupler FA. Coronary insufficiency and 5-fluorouracil therapy. A case report, review, and suggestion regarding mechanism. Cleve Clin Q 1983; 50: 29–31
   PubMedGoogle Scholar
• Fassio T, Canobbio L, Gasparini G, Villani F. Paroxysmal supraventricular tachycardia during treatment with cisplatin and etoposide combination. Oncology 1986; 43: 219–20
   PubMed Web of Science ®Google Scholar
• Talley R W, O'Bryan R M, Gutterman J U, Brownlee R W, McCredie KB. Clinical evaluation of toxic effects of cis-diammine dichloroplatinum (NSC-119875). Phase I clinical study. Cancer Chemother Rep 1973; 57: 465–71
   PubMedGoogle Scholar
• Tomirotti M, Riundi R, Pulici S, et al. Ischemic cardiopathy from cis-diamminedichloroplatinum (CDDP). Tumori 1984; 70: 235–6
   PubMed Web of Science ®Google Scholar
• Eskilsson J, Albertsson M, Mercke C. Adverse cardiac effects during induction chemotherapy treatment with cis-platin and 5-fluorouracil. Radiother Oncol 1988; 13: 41–6
   PubMed Web of Science ®Google Scholar
• Carey R W, Hilgenberg A D, Wilkins E W, Choi N C, Mathisen D J, Grillo H. Preoperative chemotherapy followed by surgery with possible postoperative radiotherapy in squamous cell carcinoma of the esophagus: Evaluation of the chemotherapy component. J Clin Oncol 1986; 4: 697–701
   PubMed Web of Science ®Google Scholar
• Kelsen D. Chemotherapy of esophageal cancer. Eur J Cancer Clin Oncol 1985; 21: 5–7
   PubMedGoogle Scholar
• Leichman L, Herskovic A, Leichman C G, et al. Nonoperative therapy for squamous-cell cancer of the esophagus. J Clin Oncol 1987; 5: 365–70
   PubMed Web of Science ®Google Scholar
• Popp M B, Hawley D, Reising J, et al. Improved survival in squamous esophageal cancer. Arch Surg 1986; 121: 1330–5
   PubMedGoogle Scholar